104.72
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$104.81
Aprire:
$104.58
Volume 24 ore:
5.52M
Relative Volume:
0.68
Capitalizzazione di mercato:
$133.62B
Reddito:
$407.94B
Utile/perdita netta:
$2.90B
Rapporto P/E:
45.99
EPS:
2.2771
Flusso di cassa netto:
$7.39B
1 W Prestazione:
+0.06%
1M Prestazione:
+17.01%
6M Prestazione:
+30.69%
1 anno Prestazione:
+57.24%
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CVS
Cvs Health Corp
|
104.72 | 131.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
UNH
Unitedhealth Group Inc
|
425.36 | 377.45B | 449.71B | 12.81B | 19.67B | 13.24 |
|
ELV
Elevance Health Inc
|
417.89 | 83.98B | 200.42B | 5.24B | 6.45B | 23.50 |
|
CI
Cigna Group
|
287.77 | 72.93B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
396.75 | 47.69B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
Center for Wealth Management Advisory Has $279,000 Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Medicare Expands Coverage for GLP-1 Weight Loss Drugs, Retailers Step In - GuruFocus
CVS Health Portable Nebulizer from CVS Health Corp.quiet home breathing aid for US asthma patient - AD HOC NEWS
Choice Hotels adds CVS Health executive to board - Investing.com
CVS Health Corp. focuses on pharmacy and health services as investors watch the stock. Long-term str - AD HOC NEWS
US firms score roles on the $69bn CVS Health Aetna merger - McDermott Will & Schulte
Pictet Asset Management Holding SA Sells 277,329 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Symphonymedication adherence tool quietly reshapes home care - AD HOC NEWS
CVS Health Exec Explains Why Its Support of America250 is ‘Natural Fit’ - Yahoo Finance
The CVS Health Virtual Primary CareRemote visits reshape routine care - AD HOC NEWS
CVS Health Corp. faces Florida antitrust probe as analysts turn more positive - AD HOC NEWS
CVS Health: The Health Screenings Men Shouldn't Skipand How CVS Health Makes Them Easier - FinanzNachrichten.de
CVS Health Corporation $CVS Shares Sold by Janney Montgomery Scott LLC - MarketBeat
Form 4 CVS Health Corp For: 29 June By Investing.com - Investing.com Canada
PBMs Drop Fight To Pause Insulin Case Amid Deal Talks - Law360
Executive at CVS (CVS) has 454 restricted shares withheld for FICA taxes - Stock Titan
CVS Beats Suit on Health Plan Pharmacy Restrictions at Eighth Cir. - Bloomberg Law News
States Seek to Lower Drug Prices by Targeting Pharmacy Benefit Managers - MedPage Today
CVS Health Corporation (CVS) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
How CVS Health Is Helping America Celebrate Its 250th Anniversary - ACCESS Newswire
CVS Health strategy shifts toward GLP-1 demand, shares stay anchored in the S&P 500 - AD HOC NEWS
CVS Health Corporation $CVS Position Cut by Patton Fund Management Inc. - MarketBeat
Patriot Financial Group Insurance Agency LLC Acquires 15,746 Shares of CVS Health Corporation $CVS - MarketBeat
Canoe Financial LP Purchases 270,798 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health (NYSE:CVS) Rating Lowered to Hold at Wall Street Zen - MarketBeat
The CVS CarePass membership from CVS Health Corp.same-day perks change the pharmacy routine - AD HOC NEWS
Mobile women’s health clinic plans stops this week in Piedmont, Doniphan and Poplar Bluff - Dexter Statesman
Mobile women’s health clinic plans stops this week in Piedmo... - Delta Dunklin Democrat
The CVS Digestive Health Gummies from CVS Health Corp.a quiet longseller on the pharmacy shelf - AD HOC NEWS
Mark Cuban warns insurers could sabotage healthcare reform - AOL.com
CVS Health consensus builds among analysts, shares backed by Moderate Buy stance - Ad-hoc-news.de
States seek to regulate companies’ drug prices - The Arkansas Democrat-Gazette
CVS Health Corporation $CVS Shares Bought by Fort Washington Investment Advisors Inc. OH - MarketBeat
Adams Diversified Equity Fund Inc. Sells 150,600 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation (NYSE:CVS) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Millions drop Obamacare health coverage after subsidies expire and costs rise - AOL.com
States seek to lower drug prices by targeting the companies that manage them for health plans - VailDaily.com
CVS HealthHub from CVS Health Corp.in-store clinics push primary care - Ad-hoc-news.de
Sterling Capital Management LLC Has $8.39 Million Stake in CVS Health Corporation $CVS - MarketBeat
Value Partners Investments Inc. Has $38.82 Million Stock Position in CVS Health Corporation $CVS - MarketBeat
Louisiana State Employees Retirement System Acquires New Stake in CVS Health Corporation $CVS - MarketBeat
Econ Financial Services Corp Acquires 18,992 Shares of CVS Health Corporation $CVS - MarketBeat
HIV is now a manageable chronic condition — how CVS Specialty helps patients start and stay on treatment - CVS Health
CVS Health faces Florida probe into Caremark, shares trade near analyst targets - Ad-hoc-news.de
OLD National Bancorp IN Reduces Position in CVS Health Corporation $CVS - MarketBeat
OP Asset Management Ltd Takes $9.27 Million Position in CVS Health Corporation $CVS - MarketBeat
Assenagon Asset Management S.A. Reduces Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Bought by Banque Cantonale Vaudoise - MarketBeat
CVS Health (CVS) Stock Sees Modest Fair Value Lift As GLP 1 And Margins Help - Yahoo Finance
CVS Health raises 2026 guidance, shares trade in S&P 500 healthcare mix - Ad-hoc-news.de
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):